BELL PLAINE, Minn. — Bell Pharmaceuticals has added Jet-Avert, a new product for motion sickness, to its Jet line of products.

Jet-Avert is fast acting, according to the company, and comes in small mini tabs to help provide day-long protection from nausea, dizziness and vomiting.

Available in 24- and 100-count sizes, the new product is being supported with a national advertising campaign, including web advertising, social media, and in-store promotions. Jet-Avert is also being cross-promoted with the company’s Jet-Alert, which is described as America’s best-selling caffeine tablet.

Bell Pharmaceuticals also offers contract manufacturing and packaging services, and its manufacturing capabilities include both liquid and solid dose forms.